METHODS OF TREATMENT OF SYMPTOMATIC UTERINE FIBROIDS THROUGH THE PRISM OF TIME (REVIEW OF SCIENTIFIC LITERATURE)
Main Article Content
Abstract
The review article presents the results of the published works, concerning the studies of therapy of symptomatic uterine fibroids. As known, uterine fibroids takes the second place in the structure of gynecological pathology without downtrend. Conducted investigations demonstrate ambiguous results in the use of surgical and minimal invasive methods of treatment. Part of the authors lean toward the election of myomectomy as a method with the minimal influence on fertility and excluding the disease recurrence.
The group of investigators, adherents of more sparing approaches to the organ-preserving tactics substantiate and prove the expediency of making the embolization of uterine arteries, taking into consideration the individual approach and risk assessment of long-term results.
Discussability of the questions of choosing the methods of treatment of symptomatic uterine fibroids, taking into the consideration a long-term exodus and perspective of the realization the reproductive function determine the necessity of conducting further perspective investigations.
Keywords
Article Details
Information about financing and conflict of interests
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.
This work is licensed under a Creative Commons Attribution 4.0 License.
How to Cite
References
Dolmans MM, Donnez J, Fellah L. Uterine fibroid management: Today and tomorrow. J Obstet Gynaecol Res. 2019; 45(7): 1222-1229. DOI: 10.1111/jog.14002
Szkodziak P, Pyra K, Szkodziak F, Krzyżanowski J, Czuczwar P, Woźniak S, et al. The Lublin Protocol of the Uterine Arteries Embolization in the Treatment of Symptomatic Uterine Fibroids. J Vis Exp. 2020; (163). DOI: 10.3791/61530
Donnez J, Dolmans MM. Uterine fibroid management: from the present to the future. Hum Reprod Update. 2016; 22(6): 665-686. DOI: 10.1093/humupd/dmw023
Pan H, Qin F, Deng F. Clinical Value of Body Mass Index and Waist-Hip Ratio in Clinicopathological Characteristics and Prognosis of Uterine Leiomyomata. Evid Based Complement Alternat Med. 2021; 2021: 8156288. DOI: 10.1155/2021/8156288
Kwas K, Nowakowska A, Fornalczyk A, Krzycka M, Nowak A, Wilczyński J, Szubert M. Impact of Contraception on Uterine Fibroids. Medicina (Kaunas). 2021; 57(7): 717. DOI: 10.3390/medicina57070717
McWilliams MM, Chennathukuzhi VM. Recent Advances in Uterine Fibroid Etiology. Semin Reprod Med. 2017; 35(2): 181-189. DOI: 10.1055/s-0037-1599090
Laughlin-Tommaso SK, Stewart EA. Moving Toward Individualized Medicine for Uterine Leiomyomas. Obstet Gynecol. 2018; 132(4): 961-971. DOI: 10.1097/AOG.0000000000002785
American College of Obstetricians and Gynecologists. ACOG practice bulletin. Alternatives to hysterectomy in the management of leiomyomas. Obstet Gynecol. 2008; 112: 387e400
Ravina JH, Herbreteau D, Ciraru-Vigneron N, et al. Arterial embolization to treat uterine myomata. Lancet. 1995; 346: 671-672
Goodwin SC, Vedantham S, McLucas B, et al. Preliminary experience with uterine artery embolization for uterine fibroids. J Vasc Interv Radiol. 1997; 8: 517-526
Spies JB, Sci ali AR, Jha RC, et al. Initial results from uterine fibroid embolization for symptomatic leiomyomata. J Vasc Interv Radiol. 1999; 10(9): 1149-1157
Hutchins Jr FL, Worthington-Kirsch R, Berkowitz RP. Selective uterine artery embolization as primary treatment for symptomatic leiomyomata uteri. J Am Assoc Gynecol Laparosc. 1999; 6(3): 279-284
Walker WJ, Pelage JP. Uterine artery embolization for symptomatic fibroids: clinical result in 400 women with imaging follow up. BJOG. 2002; 109(11): 1262-1272
Pron G, Cohen M, Soucie J, et al., Ontario Uterine Fibroid Embolization Collaboration Group. The Ontario Uterine Fibroid Embolization Trial. Part 1. Baseline patient characteristics, fibroid burden, and impact on life. Fertil Steril. 2003; 79(1): 112-119
Myers ER, Goodwin S, Landow W, et al., FIBROID Investigators. Prospective data collection of a new procedure by a specialty society: the FIBROID registry. Obstet Gynecol. 2005; 106(1): 44-51
Spies JB, Coyne K, Guaou Guaou N, et al. The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Obstet Gynecol. 2002; 99(2): 290-300
Spies JB, Bradley LD, Guido R, et al. Outcomes from leiomyoma therapies: comparison with normal controls. Obstet Gynecol. 2010; 116(3): 641-652
Spies JB, Myers ER, Worthington-Kirsch R, et al., FIBROID Registry Investigators. The FIBROID Registry: symptom and quality-of-life status 1 year after therapy. Obstet Gynecol. 2005; 106(6): 1309-1318
Costa KR, Metzger PB. Endovascular treatment of uterine myomatosis: a systematic review. J Vasc Bras. 2020; 19: e20190149. DOI: 10.1590/1677-5449.190149
Donnez J, Dolmans MM. Uterine fibroid management: from the present to the future. Hum Reprod Update. 2016; 22(6): 665-686. DOI: 10.1093/humupd/dmw023
Tulandi T, Leung A, Jan N. Nonmalignant Sequelae of Unconfined Morcellation at Laparoscopic Hysterectomy or Myomectomy. J Minim Invasive Gynecol. 2016; 23(3): 331-337. DOI: 10.1016/j.jmig.2016.01.017
Cucinella G, Granese R, Calagna G, Somigliana E, Perino A. Parasitic myomas after laparoscopic surgery: an emerging complication in the use of morcellator? Description of four cases. Fertil Steril. 2011; 96(2): e90-6. DOI: 10.1016/j.fertnstert.2011.05.095
Lete I, González J, Ugarte L, Barbadillo N, Lapuente O, Álvarez-Sala J. Parasitic leiomyomas: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2016; 203: 250-259. DOI: 10.1016/j.ejogrb.2016.05.025
Lu B, Xu J, Pan Z. Iatrogenic parasitic leiomyoma and leiomyomatosis peritonealis disseminata following uterine morcellation. J Obstet Gynaecol Res. 2016; 42(8) :990-999. DOI: 10.1111/jog.13011
Cohen SL, Morris SN, Brown DN, Greenberg JA, Walsh BW, Gargiulo AR, et al. Contained tissue extraction using power morcellation: prospective evaluation of leakage parameters. Am J Obstet Gynecol. 2016; 214: 257.e1-257.e6
Food and Drug Administration. Quantitative assessment of the prevalence of unsuspected uterine sarcoma in women undergoing treatment of uterine fibroids. In: Food and Drug Administration [Internet]. Available from: https://www.fda.gov/media/88703/download
Willson JR, Peale AR. Multiple peritoneal leiomyomas associated with a granulosa-cell tumor of the ovary. Am J Obstet Gynecol. 1952; 64(1): 204-208. DOI: 10.1016/s0002-9378(16)38757-9
Taubert HD, Wissner SE, Haskins AL. Leiomyomatosis peritonealis disseminata; an unusual complication of genital leiomyomata. Obstet Gynecol. 1965; 25: 561-574
Gaichies L, Fabre-Monplaisir L, Fauvet R, Alves A, Mulliri A. Leiomyomatosis peritonealisis disseminata: Two unusual cases with literature review. J Gynecol Obstet Hum Reprod. 2018; 47(2): 89-94. DOI: 10.1016/j.jogoh.2017.11.011
Van der Meulen JF, Pijnenborg JM, Boomsma CM, Verberg MF, Geomini PM, Bongers MY. Parasitic myoma after laparoscopic morcellation: a systematic review of the literature. BJOG. 2016; 123(1): 69-75. DOI: 10.1111/1471-0528.13541
Wen CY, Lee HS, Lin JT, Yu CC. Disseminated peritoneal leiomyomatosis with malignant transformation involving right ureter: A case report. World J Clin Cases. 2022; 10(5): 1639-1644. DOI: 10.12998/wjcc.v10.i5.1639
Chen X, Liu H, Shi H, Fan Q, Sun D, Lang J. Leiomyomatosis Peritonealis Disseminata Following Laparoscopic Surgery With Uncontained Morcellation: 13 Cases From One Institution. Front Surg. 2021; 8: 788749. DOI: 10.3389/fsurg.2021.788749
Lu B, Xu J, Pan Z. Iatrogenic parasitic leiomyoma and leiomyomatosis peritonealis disseminata following uterine morcellation. J Obstet Gynaecol Res. 2016; 42(8): 990-999. DOI: 10.1111/jog.13011
Goldberg J, Pereira L, Berghella V, et al. Pregnancy outcomes after treatment for fibromyomata: uterine artery embolization versus laparoscopic myomectomy. Am J Obstet Gynecol. 2004; 191: 18-21
Homer H, Saridogan E. Uterine artery embolization for fibroids is associated with an increased risk of miscarriage. Fertil Steril. 2010; 94: 324-330
Pisco JM, Duarte M, Bilhim T, et al. Pregnancy after uterine fibroid embolization. Fertil Steril. 2011; 95(3): 1121.e5-8. DOI: 10.1016/j.fertnstert.2010.08.032
Mohan PP, Hamblin MH, Vogelzang RL. Uterine artery embolization and its effect on fertility. J Vasc Interv Radiol. 2013; 24: 925e30
Gupta JK, Sinha A, Lumsden MA, Hickey M. Uterine artery embolization for symptomatic uterine fibroids. Cochrane Q7 Database Syst Rev. 2014; 12: CD005073
Lacayo EA, Richman DL, Acord MR, et al. Leiomyoma infarction after uterine artery embolization: influence of embolic Q6 agent and leiomyoma size and location on outcome. J Vasc Interv Radiol. 2017; 28(7): 1003-1010. DOI: 10.1016/j.jvir.2017.03.015
Dobrokhotova YuE, Knysheva IG, Dzhobava EM, Grishin II, Danelyan SZh. Uterine artery embolization and pregnancy: debatable questions. Journal Obstetrics and Gynecology. 2013; 5: 42-47. Russian (Доброхотова Ю.Э., Кнышева И.Г., Джобава Э.М., Гришин И.И., Данелян С.Ж. Эмболизация маточных артерий и беременность: дискуссионные вопросы //Акушерство и гинекология. 2013. №5. С. 42-47)
Vysotskiy MM, Kuranov II, Nevzorov OB. Indicators of the reproductive function after endoscopic surgical treatment of uterine myomas. Obstetrics, Gynecology and Reproduction. 2019; 13(4): 297-304. Russian (Высоцкий М.М., Куранов И.И., Невзоров О.Б. Показатели репродуктивной функции после эндоскопического хирургического лечения миомы матки //Акушерство, гинекология и репродукция. 2019. Т. 13, № 4. С. 297-304.) DOI: 10.17749/2313-7347.2019.13.4.297-304
El Shamy T, Amer SAK, Mohamed AA, James C, Jayaprakasan K. The impact of uterine artery embolization on ovarian reserve: A systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2020; 99(1): 16-23. DOI: 10.1111/aogs.13698
Spies JB, Bradley LD, Guido R, et al. Outcomes from leiomyoma therapies: comparison with normal controls. Obstet Gynecol. 2010; 116(3): 641-652
Hirst A, Dutton S, Wu O, et al. A multi-centre retrospective cohort study comparing the efficacy, safety and costeffectiveness of hysterectomy and uterine artery embolisation for the treatment of symptomatic uterine fibroids. The HOPEFUL study. Health Technol Assess. 2008; 12(5): 1-248
Hehenkamp WJ, Volkers NA, Donderwinkel PF, et al. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): peri- and postprocedural results from a randomized controlled trial. Am J Obstet Gynecol. 2005; 193(5): 1618-1629
Ananthakrishnan G, Murray L, Ritchie M, et al. Randomized comparison of uterine artery embolization (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): subanalysis of 5-year MRI findings. Cardiovasc Interv Radiol. 2013; 36(3): 676-681
Costa KR, Metzger PB. Endovascular treatment of uterine myomatosis: a systematic review. J Vasc Bras. 2020; 19: e20190149. DOI: 10.1590/1677-5449.190149
Xu F, Deng L, Zhang L, Hu H, Shi Q. The comparison of myomectomy, UAE and MRgFUS in the treatment of uterine fibroids: a meta analysis. Int J Hyperthermia. 2021; 38(2): 24-29. DOI: 10.1080/02656736.2021.1933216